United Capital Financial Advisors LLC Invests $872,000 in Globe Life Inc. $GL

United Capital Financial Advisors LLC bought a new stake in Globe Life Inc. (NYSE:GL) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 4,879 shares of the company’s stock, valued at approximately $872,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in GL. Hayek Kallen Investment Management acquired a new position in Globe Life during the 2nd quarter worth approximately $612,000. Jefferies Financial Group Inc. acquired a new stake in Globe Life in the second quarter valued at approximately $1,252,000. Public Employees Retirement System of Ohio acquired a new stake in Globe Life in the second quarter valued at approximately $4,319,000. Capstone Investment Advisors LLC bought a new stake in shares of Globe Life during the second quarter valued at approximately $1,327,000. Finally, Redwood Investment Management LLC acquired a new position in shares of Globe Life during the second quarter worth approximately $1,164,000. 81.61% of the stock is owned by institutional investors.

Globe Life Price Performance

Shares of NYSE:GL opened at $173.41 on Monday. The firm has a market capitalization of $13.33 billion, a PE ratio of 11.51 and a beta of 0.48. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The company has a 50-day moving average price of $178.77 and a two-hundred day moving average price of $159.66. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The company’s revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts forecast that Globe Life Inc. will post 15.71 EPS for the current year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life’s dividend payout ratio (DPR) is 8.76%.

Globe Life declared that its board has initiated a stock repurchase program on Monday, August 10th that authorizes the company to buyback $2.50 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 17.7% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Analysts Set New Price Targets

GL has been the topic of a number of analyst reports. Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th. Morgan Stanley raised their target price on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. Wells Fargo & Company increased their price target on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Piper Sandler raised their price objective on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $191.67.

Insider Activity at Globe Life

In other Globe Life news, Director Cheryl Alston sold 8,258 shares of Globe Life stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the completion of the sale, the director directly owned 16,621 shares in the company, valued at $2,979,148.04. The trade was a 33.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO James Matthew Darden sold 50,000 shares of the company’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the completion of the transaction, the chief executive officer owned 58,451 shares of the company’s stock, valued at $10,663,215.93. This trade represents a 46.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 151,908 shares of company stock valued at $27,239,981 in the last ninety days. Insiders own 2.11% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.